BioInvent International AB (publ) (STO:BINV)
38.00
-0.90 (-2.31%)
Aug 1, 2025, 5:29 PM CET
Chimerix Market Cap
STO:BINV has a market cap or net worth of 2.50 billion as of August 1, 2025. Its market cap has increased by 0.26% in one year.
Market Cap
2.50B
Enterprise Value
1.77B
Revenue
60.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
$38.00
Market Cap Chart
Since June 14, 2001, STO:BINV's market cap has increased from 1.20B to 2.50B, an increase of 107.55%. That is a compound annual growth rate of 3.07%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 2.50B | -1.30% |
Dec 30, 2024 | 2.53B | 103.06% |
Dec 29, 2023 | 1.25B | -40.08% |
Dec 30, 2022 | 2.08B | -22.92% |
Dec 30, 2021 | 2.70B | 54.06% |
Dec 30, 2020 | 1.75B | 185.96% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Swedish Orphan Biovitrum AB | 91.11B |
Sectra AB | 69.94B |
Getinge AB | 51.61B |
Camurus AB | 40.70B |
Medicover AB | 40.61B |
Asker Healthcare Group AB | 38.41B |
Bonesupport Holding AB | 21.77B |
AddLife AB | 20.67B |